I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| plasmacytoid dendritic cell | 7 studies | 25% ± 8% | |
| classical monocyte | 6 studies | 22% ± 7% | |
| epithelial cell | 6 studies | 39% ± 16% | |
| CD8-positive, alpha-beta T cell | 6 studies | 21% ± 4% | |
| natural killer cell | 6 studies | 19% ± 4% | |
| CD4-positive, alpha-beta T cell | 5 studies | 26% ± 5% | |
| plasmablast | 4 studies | 40% ± 20% | |
| conventional dendritic cell | 4 studies | 26% ± 8% | |
| goblet cell | 4 studies | 25% ± 10% | |
| basal cell | 4 studies | 32% ± 16% | |
| regulatory T cell | 4 studies | 20% ± 3% | |
| hematopoietic precursor cell | 3 studies | 29% ± 4% | |
| non-classical monocyte | 3 studies | 32% ± 5% | |
| transit amplifying cell | 3 studies | 28% ± 3% | |
| type I pneumocyte | 3 studies | 28% ± 8% | |
| ciliated cell | 3 studies | 27% ± 2% | |
| macrophage | 3 studies | 24% ± 4% | |
| dendritic cell | 3 studies | 36% ± 5% | |
| enterocyte | 3 studies | 21% ± 3% |
